ABDERA THERAPEUTICS
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeutic and commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030. It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.
ABDERA THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Life Science
Founded:
2021-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.abderatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
604.827.1147
Total Funding:
8 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Official Site Inspections
http://www.abderatherapeutics.com Semrush global rank: 7.06 M Semrush visits lastest month: 615
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abdera Therapeutics"
Abdera Therapeutics - LinkedIn
Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development.See details»
adMare Launches Abdera with AbCellera as a Founding Partner
VANCOUVER, BC, Jan. 14, 2021 /CNW/ - adMare BioInnovations, Canada's global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with …See details»
AbCellera's Partners
We strategically partner with groups that have novel science and innovative technology to develop antibody-based medicines.See details»
Abdera Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Abdera Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Abdera Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Abdera Therapeutics Inc. of Saint-Laurent, QC. Get the latest business insights from Dun & Bradstreet.See details»
Abdera Therapeutics
Abdera’s ROVErâ„¢ platform integrates cutting-edge drug discovery and antibody engineering technologies to advance novel radiopharmaceutical-based cancer medicines with tunable PK properties focused on maximizing therapeutic …See details»
Abdera Therapeutics’s Competitors, Revenue, Number of ... - Owler
Abdera Therapeutics’s Profile, Revenue and Employees. Abdera is a Canada-based biopharmaceutical company that discovers and develops precision radiopharmaceutical …See details»
Who Owns Abdera Therapeutics – CANVAS, SWOT, …
Dec 19, 2024 As the world eagerly awaits more information on the true ownership of Abdera Therapeutics, the excitement and intrigue surrounding this cutting-edge organization continue to grow.See details»
adMare Launches Abdera with AbCellera as a Founding Partner
Jan 14, 2021 adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with founding partner, AbCellera …See details»
Careers • Abdera
Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies, one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary …See details»
Abdera Therapeutics
About: Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug …See details»
A Brief History of Abdera Therapeutics - canvasbusinessmodel.com
Dec 19, 2024 A Brief History of Abdera Therapeutics: Founded in 2008 by a team of renowned scientists and medical professionals, Abdera Therapeutics has carved out a unique niche in …See details»
Abdera Therapeutics Announces FDA Orphan Drug Designation …
Sep 5, 2024 SOUTH SAN FRANCISCO, CA, September 5, 2024 – Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVErâ„¢ platform …See details»
Platform • Abdera
Abdera’s differentiated approach to radiopharmaceutical drug discovery and development leverages the capabilities of our Radio Optimized Vector Engineering (ROVErâ„¢) platform. We …See details»
How Does Abdera Therapeutics Company Work?
Jul 11, 2025 Decoding Abdera Therapeutics: How Does It Conquer Cancer? Abdera Therapeutics, a rising star in the biopharmaceutical company arena, is making waves with its …See details»
Abdera Therapeutics Headquarters and Office Locations - Craft
Abdera Therapeutics Headquarters and Office Locations Abdera Therapeutics is headquartered in Menlo Park, 535 Middlefield Road Suite 240, United States, and has 2 office locations.See details»
Abdera Therapeutics Debuts With $142 Million in Financing to …
Apr 20, 2023 MENLO PARK, CA and VANCOUVER, British Columbia, April 20, 2023 – Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering …See details»
Patients - Abdera
We are here to make a difference. Abdera is here to walk beside you through every step of your cancer journey. Whether you’ve just been diagnosed, are undergoing treatment, or are in …See details»
Press Releases: Archive • Abdera
Jun 27, 2024 Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer ReadSee details»